Sulfonic acid or sulfonylamino N-(heteroaralkyl)-azaheterocyclylamide compounds
The compounds of formula I herein exhibit useful pharmacological activity and accordingly are incorporated into pharmaceutical compositions and used in the treatment of patients suffering from certain medical disorders. More specifically, they are inhibitors of the activity of Factor Xa. The present invention is directed to compounds of formula I, compositions containing compounds of formula I, and their use, which are for treating a patient suffering from, or subject to, physiological condition which can be ameliorated by the administration of an inhibitor of the activity of Factor Xa.
Aventis Pharma Deutschland GmbH
C C C A A A A C A A C C C A A C A C A A A A A A A
C07D C07D C07D A61K A61P A61K A61P C07D A61K A61K C07D C07D C07D A61K A61P C07D A61P C07D A61P A61K A61P A61K A61K A61P A61K
inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional
Yong Daniel M. Yong Mi Jeffrey N. Michael R. Henry W. William R.
Gong Green Choi-Sledeski Barton Becker Pauls Ewing